Alterity Therapeutics ATHE
NASDAQ ATHE
$2.09 -0.06 (-2.85%)
As of: Oct 23, 2026 · 1:17 PM EDT

Alterity Therapeutics (ATHE) Operating Income (2016 - 2018)

Updated

Alterity Therapeutics' Operating Income came in at -$3.86 million for the year ended Dec 31, 2019.

Analysis

Alterity Therapeutics (ATHE) Operating Income (2016 - 2018) Analysis & Trends

Going back to the year ended Jun 30, 2010, Alterity Therapeutics' Operating Income data covers 4 years.

  • The figure for the year ended Dec 31, 2019 represents the highest annual Operating Income since the year ended Jun 30, 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Eli Lilly 1,126.20 Bn 1,094.78 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 633.36 Bn 553.22 Bn 17.30 Bn 6.18 Bn
3 AbbVie 504.51 Bn 477.62 Bn 12.70 Bn 6.43 Bn
4 Merck 357.58 Bn 311.96 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 289.65 Bn 253.64 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 264.97 Bn 238.66 Bn 12.86 Bn 3.16 Bn
7 Amgen 237.69 Bn 193.09 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 194.48 Bn 168.68 Bn 6.22 Bn -10.39 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn 4.27 Bn
10 Alterity Therapeutics 36.66 Mn -46.49 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -3.83 Mn
Dec 31, 2017 -2.78 Mn
Dec 31, 2016 -2.74 Mn
API Access

Alterity Therapeutics Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=ATHE&period=max&api_key=YOUR_API_KEY